Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $11.6 million.

  • Inspire Medical Systems' Change in Receivables rose 19460.62% to $11.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.2 million, marking a year-over-year increase of 90818.6%. This contributed to the annual value of $26.2 million for FY2025, which is 90818.6% up from last year.
  • As of Q4 2025, Inspire Medical Systems' Change in Receivables stood at $11.6 million, which was up 19460.62% from -$29.7 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Change in Receivables ranged from a high of $44.6 million in Q2 2025 and a low of -$29.7 million during Q3 2025
  • For the 5-year period, Inspire Medical Systems' Change in Receivables averaged around $4.8 million, with its median value being $5.2 million (2022).
  • In the last 5 years, Inspire Medical Systems' Change in Receivables surged by 50036.9% in 2021 and then plummeted by 117347.21% in 2024.
  • Inspire Medical Systems' Change in Receivables (Quarter) stood at $7.5 million in 2021, then surged by 68.27% to $12.6 million in 2022, then soared by 47.6% to $18.6 million in 2023, then tumbled by 78.8% to $3.9 million in 2024, then soared by 194.61% to $11.6 million in 2025.
  • Its Change in Receivables was $11.6 million in Q4 2025, compared to -$29.7 million in Q3 2025 and $44.6 million in Q2 2025.